Ariola Koci
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
- Drug-Induced Adverse Reactions
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 7
-
- Cardiac electrophysiology and arrhythmias 5
- Co-authors
- Fabrizio De Ponti (15 shared papers)Elisabetta Poluzzi (15 shared papers)Emanuel Raschi (13 shared papers)Ugo Moretti (6 shared papers)Miriam Sturkenboom (5 shared papers)Paolo Caraceni (1 shared paper)Brian Godman (3 shared papers)Marija Kalaba (2 shared papers)
- Journals
- Drug Safety (2 papers)Clinical Therapeutics (2 papers)European Journal of Clinical Pharmacology (2 papers)PLoS ONE (2 papers)Nutrition Metabolism and Cardiovascular Diseases (1 paper)
- Partner nations
- ItalyUnited KingdomNetherlands
In The Last Decade
Ariola Koci
16 papers receiving 380 citations
Peers
Comparison fields: 5 of 91
- Toxicology 76
- Pharmacology 60
- Internal Medicine 19
- Cardiology and Cardiovascular Medicine 111
- Psychiatry and Mental health 61
Countries citing papers authored by Ariola Koci
This map shows the geographic impact of Ariola Koci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariola Koci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariola Koci more than expected).
Fields of papers citing papers by Ariola Koci
This network shows the impact of papers produced by Ariola Koci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariola Koci. The network helps show where Ariola Koci may publish in the future.
Co-authors
The 25 scholars most cited alongside Ariola Koci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 62 | |
| 2 | 2013 | 57 | |
| 3 | 2014 | 54 | |
| 4 | 2015 | 53 | |
| 5 | 2013 | 45 | |
| 6 | 2016 | 28 | |
| 7 | 2016 | 19 | |
| 8 | 2015 | 17 | |
| 9 | 2017 | 14 | |
| 10 | 2012 | 12 | |
| 11 | 2017 | 7 | |
| 12 | 2014 | 6 | |
| 13 | 2015 | 5 | |
| 14 | 2015 | 3 | |
| 15 | 2015 | 3 | |
| 16 | 2015 | 1 |
About Ariola Koci
Ariola Koci is a scholar working on Toxicology, Cardiology and Cardiovascular Medicine, Pharmacology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 16 papers that have together received 386 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (7 papers), Cardiac electrophysiology and arrhythmias (5 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Drug-Induced Adverse Reactions (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Schizophrenia research and treatment (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Toxicology (76 citations), Pharmacology (60 citations), Internal Medicine (19 citations), Cardiology and Cardiovascular Medicine (111 citations) and Psychiatry and Mental health (61 citations). Ariola Koci has collaborated with scholars based in Italy, United Kingdom and Netherlands. Frequent co-authors include Fabrizio De Ponti, Elisabetta Poluzzi, Emanuel Raschi, Ugo Moretti, Miriam Sturkenboom, Paolo Caraceni, Brian Godman, Marija Kalaba, Björn Wettermark and Francesco Salvo. Their work appears in journals such as Drug Safety, Clinical Therapeutics, European Journal of Clinical Pharmacology, PLoS ONE and Nutrition Metabolism and Cardiovascular Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.